Neutralizing the adverse effects of cyclophosphamide on the mouse testis and sperm parameters through pentoxifylline: A molecular and stereological study

Cyclophosphamide (CP) is one of the chemotherapeutic drugs, which plays its role by interfering with all rapidly proliferating tissues like cancer and testis. The aim of this study was to investigate the protective effect of pentoxifylline (PTX) on the sperm parameters, spermatogenesis indices, bioc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Andrologia 2022-11, Vol.54 (10), p.e14543-n/a
Hauptverfasser: Mahmoodi, Monireh, Bakhshi, Sepideh, Sadeghzadeh, Firouzeh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 10
container_start_page e14543
container_title Andrologia
container_volume 54
creator Mahmoodi, Monireh
Bakhshi, Sepideh
Sadeghzadeh, Firouzeh
description Cyclophosphamide (CP) is one of the chemotherapeutic drugs, which plays its role by interfering with all rapidly proliferating tissues like cancer and testis. The aim of this study was to investigate the protective effect of pentoxifylline (PTX) on the sperm parameters, spermatogenesis indices, biochemical alterations and gene expressions, in adult male mice treated with CP. A total of 24 male NMRI mice were divided into four groups: control, CP group (15 mg/kg weekly), PTX (100 mg/kg daily) and CP + PTX and treated for 35 days with the intraperitoneal injection. A significant decrease in the spermatogenesis indices, Leydig cells, sperm motility, viability, count, tail length and daily sperm production was found in the CP group compared to the control group. The results of this study indicate that PTX prevented these adverse effects of CP and decreased the number of apoptotic cells. Moreover, the CP group showed decreased levels of total antioxidant capacity, testosterone, lipid peroxidation and the expression of cytochrome P450 and 3β‐hydroxysteroid, all of which were neutralized in the CP + PTX group. It seems that PTX has the potential to be used in therapeutic regimens of cancer patients to reduce the side effects of CP. However, more research is needed to evaluate this prevention in mice models of cancer.
doi_str_mv 10.1111/and.14543
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2720433491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2720433491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2533-b63d1ebd4d0bf3b5206b4b05cfe4c99a834e08b0ef19e1fecc3838f4e93c71823</originalsourceid><addsrcrecordid>eNp10c1OxCAQB3BiNHGjHnwDEi966AqF7rbeNn4nRi96bigddjG0VGjV-ia-raP1ZOJcCMlvBv5AyCFnc451qtp6zmUmxRaZcSmKhKXLdJvMmGAikdmi2CUHMT4zLJktl1LOyOc9DH1Qzn7Ydk37DVBVv0KIQMEY0H2k3lA9aue7jY_dRjW2BurbH9r4AWEPsbeR4uE0dhAa2qmgGuhxCqrgh_WGdtD2_t2a0TnbwhldYa8DPTgVpkbU4J1fW60c7oZ63Cc7RrkIB7_rHnm6unw8v0nuHq5vz1d3iU4zIZJqIWoOVS1rVhlRZSlbVLJimTYgdVGoXEhgecXA8AI4RtIiF7mRUAi95Hkq9sjxNLcL_mXALGVjowbnVAuYr8QnZFIIWXCkR3_osx9Ci7f7ViLlaZrlqE4mpYOPMYApu2AbFcaSs_L7n0pMXP78E9rTyb5ZB-P_sFzdX0wdXwQpl9I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2723212258</pqid></control><display><type>article</type><title>Neutralizing the adverse effects of cyclophosphamide on the mouse testis and sperm parameters through pentoxifylline: A molecular and stereological study</title><source>Wiley Online Library All Journals</source><creator>Mahmoodi, Monireh ; Bakhshi, Sepideh ; Sadeghzadeh, Firouzeh</creator><creatorcontrib>Mahmoodi, Monireh ; Bakhshi, Sepideh ; Sadeghzadeh, Firouzeh</creatorcontrib><description>Cyclophosphamide (CP) is one of the chemotherapeutic drugs, which plays its role by interfering with all rapidly proliferating tissues like cancer and testis. The aim of this study was to investigate the protective effect of pentoxifylline (PTX) on the sperm parameters, spermatogenesis indices, biochemical alterations and gene expressions, in adult male mice treated with CP. A total of 24 male NMRI mice were divided into four groups: control, CP group (15 mg/kg weekly), PTX (100 mg/kg daily) and CP + PTX and treated for 35 days with the intraperitoneal injection. A significant decrease in the spermatogenesis indices, Leydig cells, sperm motility, viability, count, tail length and daily sperm production was found in the CP group compared to the control group. The results of this study indicate that PTX prevented these adverse effects of CP and decreased the number of apoptotic cells. Moreover, the CP group showed decreased levels of total antioxidant capacity, testosterone, lipid peroxidation and the expression of cytochrome P450 and 3β‐hydroxysteroid, all of which were neutralized in the CP + PTX group. It seems that PTX has the potential to be used in therapeutic regimens of cancer patients to reduce the side effects of CP. However, more research is needed to evaluate this prevention in mice models of cancer.</description><identifier>ISSN: 0303-4569</identifier><identifier>EISSN: 1439-0272</identifier><identifier>DOI: 10.1111/and.14543</identifier><language>eng</language><publisher>Berlin: Wiley Subscription Services, Inc</publisher><subject>Animal models ; Apoptosis ; Cancer ; Cyclophosphamide ; Cytochrome P450 ; infertility ; Leydig cells ; Lipid peroxidation ; pentoxifylline ; Side effects ; Sperm ; Spermatogenesis ; testis ; Testosterone</subject><ispartof>Andrologia, 2022-11, Vol.54 (10), p.e14543-n/a</ispartof><rights>2022 Wiley‐VCH GmbH.</rights><rights>2022 Wiley‐VCH GmbH</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2533-b63d1ebd4d0bf3b5206b4b05cfe4c99a834e08b0ef19e1fecc3838f4e93c71823</cites><orcidid>0000-0003-0190-897X ; 0000-0001-8383-6150 ; 0000-0002-2400-313X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fand.14543$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fand.14543$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids></links><search><creatorcontrib>Mahmoodi, Monireh</creatorcontrib><creatorcontrib>Bakhshi, Sepideh</creatorcontrib><creatorcontrib>Sadeghzadeh, Firouzeh</creatorcontrib><title>Neutralizing the adverse effects of cyclophosphamide on the mouse testis and sperm parameters through pentoxifylline: A molecular and stereological study</title><title>Andrologia</title><description>Cyclophosphamide (CP) is one of the chemotherapeutic drugs, which plays its role by interfering with all rapidly proliferating tissues like cancer and testis. The aim of this study was to investigate the protective effect of pentoxifylline (PTX) on the sperm parameters, spermatogenesis indices, biochemical alterations and gene expressions, in adult male mice treated with CP. A total of 24 male NMRI mice were divided into four groups: control, CP group (15 mg/kg weekly), PTX (100 mg/kg daily) and CP + PTX and treated for 35 days with the intraperitoneal injection. A significant decrease in the spermatogenesis indices, Leydig cells, sperm motility, viability, count, tail length and daily sperm production was found in the CP group compared to the control group. The results of this study indicate that PTX prevented these adverse effects of CP and decreased the number of apoptotic cells. Moreover, the CP group showed decreased levels of total antioxidant capacity, testosterone, lipid peroxidation and the expression of cytochrome P450 and 3β‐hydroxysteroid, all of which were neutralized in the CP + PTX group. It seems that PTX has the potential to be used in therapeutic regimens of cancer patients to reduce the side effects of CP. However, more research is needed to evaluate this prevention in mice models of cancer.</description><subject>Animal models</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cyclophosphamide</subject><subject>Cytochrome P450</subject><subject>infertility</subject><subject>Leydig cells</subject><subject>Lipid peroxidation</subject><subject>pentoxifylline</subject><subject>Side effects</subject><subject>Sperm</subject><subject>Spermatogenesis</subject><subject>testis</subject><subject>Testosterone</subject><issn>0303-4569</issn><issn>1439-0272</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp10c1OxCAQB3BiNHGjHnwDEi966AqF7rbeNn4nRi96bigddjG0VGjV-ia-raP1ZOJcCMlvBv5AyCFnc451qtp6zmUmxRaZcSmKhKXLdJvMmGAikdmi2CUHMT4zLJktl1LOyOc9DH1Qzn7Ydk37DVBVv0KIQMEY0H2k3lA9aue7jY_dRjW2BurbH9r4AWEPsbeR4uE0dhAa2qmgGuhxCqrgh_WGdtD2_t2a0TnbwhldYa8DPTgVpkbU4J1fW60c7oZ63Cc7RrkIB7_rHnm6unw8v0nuHq5vz1d3iU4zIZJqIWoOVS1rVhlRZSlbVLJimTYgdVGoXEhgecXA8AI4RtIiF7mRUAi95Hkq9sjxNLcL_mXALGVjowbnVAuYr8QnZFIIWXCkR3_osx9Ci7f7ViLlaZrlqE4mpYOPMYApu2AbFcaSs_L7n0pMXP78E9rTyb5ZB-P_sFzdX0wdXwQpl9I</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Mahmoodi, Monireh</creator><creator>Bakhshi, Sepideh</creator><creator>Sadeghzadeh, Firouzeh</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0190-897X</orcidid><orcidid>https://orcid.org/0000-0001-8383-6150</orcidid><orcidid>https://orcid.org/0000-0002-2400-313X</orcidid></search><sort><creationdate>202211</creationdate><title>Neutralizing the adverse effects of cyclophosphamide on the mouse testis and sperm parameters through pentoxifylline: A molecular and stereological study</title><author>Mahmoodi, Monireh ; Bakhshi, Sepideh ; Sadeghzadeh, Firouzeh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2533-b63d1ebd4d0bf3b5206b4b05cfe4c99a834e08b0ef19e1fecc3838f4e93c71823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animal models</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cyclophosphamide</topic><topic>Cytochrome P450</topic><topic>infertility</topic><topic>Leydig cells</topic><topic>Lipid peroxidation</topic><topic>pentoxifylline</topic><topic>Side effects</topic><topic>Sperm</topic><topic>Spermatogenesis</topic><topic>testis</topic><topic>Testosterone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahmoodi, Monireh</creatorcontrib><creatorcontrib>Bakhshi, Sepideh</creatorcontrib><creatorcontrib>Sadeghzadeh, Firouzeh</creatorcontrib><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Andrologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahmoodi, Monireh</au><au>Bakhshi, Sepideh</au><au>Sadeghzadeh, Firouzeh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neutralizing the adverse effects of cyclophosphamide on the mouse testis and sperm parameters through pentoxifylline: A molecular and stereological study</atitle><jtitle>Andrologia</jtitle><date>2022-11</date><risdate>2022</risdate><volume>54</volume><issue>10</issue><spage>e14543</spage><epage>n/a</epage><pages>e14543-n/a</pages><issn>0303-4569</issn><eissn>1439-0272</eissn><abstract>Cyclophosphamide (CP) is one of the chemotherapeutic drugs, which plays its role by interfering with all rapidly proliferating tissues like cancer and testis. The aim of this study was to investigate the protective effect of pentoxifylline (PTX) on the sperm parameters, spermatogenesis indices, biochemical alterations and gene expressions, in adult male mice treated with CP. A total of 24 male NMRI mice were divided into four groups: control, CP group (15 mg/kg weekly), PTX (100 mg/kg daily) and CP + PTX and treated for 35 days with the intraperitoneal injection. A significant decrease in the spermatogenesis indices, Leydig cells, sperm motility, viability, count, tail length and daily sperm production was found in the CP group compared to the control group. The results of this study indicate that PTX prevented these adverse effects of CP and decreased the number of apoptotic cells. Moreover, the CP group showed decreased levels of total antioxidant capacity, testosterone, lipid peroxidation and the expression of cytochrome P450 and 3β‐hydroxysteroid, all of which were neutralized in the CP + PTX group. It seems that PTX has the potential to be used in therapeutic regimens of cancer patients to reduce the side effects of CP. However, more research is needed to evaluate this prevention in mice models of cancer.</abstract><cop>Berlin</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1111/and.14543</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-0190-897X</orcidid><orcidid>https://orcid.org/0000-0001-8383-6150</orcidid><orcidid>https://orcid.org/0000-0002-2400-313X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0303-4569
ispartof Andrologia, 2022-11, Vol.54 (10), p.e14543-n/a
issn 0303-4569
1439-0272
language eng
recordid cdi_proquest_miscellaneous_2720433491
source Wiley Online Library All Journals
subjects Animal models
Apoptosis
Cancer
Cyclophosphamide
Cytochrome P450
infertility
Leydig cells
Lipid peroxidation
pentoxifylline
Side effects
Sperm
Spermatogenesis
testis
Testosterone
title Neutralizing the adverse effects of cyclophosphamide on the mouse testis and sperm parameters through pentoxifylline: A molecular and stereological study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T18%3A11%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neutralizing%20the%20adverse%20effects%20of%20cyclophosphamide%20on%20the%20mouse%20testis%20and%20sperm%20parameters%20through%20pentoxifylline:%20A%20molecular%20and%20stereological%20study&rft.jtitle=Andrologia&rft.au=Mahmoodi,%20Monireh&rft.date=2022-11&rft.volume=54&rft.issue=10&rft.spage=e14543&rft.epage=n/a&rft.pages=e14543-n/a&rft.issn=0303-4569&rft.eissn=1439-0272&rft_id=info:doi/10.1111/and.14543&rft_dat=%3Cproquest_cross%3E2720433491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2723212258&rft_id=info:pmid/&rfr_iscdi=true